Received May 20, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| MNQ | MENINGOCOCCAL CONJUGATE (MENVEO) | NOVARTIS VACCINES AND DIAGNOSTICS | UNK | 3E99M | IM |
6-month old male was given the incorrect product formulation for his age; This non-serious case was reported by a physician via call center representative and described the occurrence of inappropriate age at vaccine administration in a 6-month-old male patient who received Men ACWY-CRM NVS (Menveo) (batch number 3E99M, expiry date 31-DEC-2025) for prophylaxis. On 21-JAN-2025, the patient received Menveo (intramuscular). On 21-JAN-2025, an unknown time after receiving Menveo, the patient experienced inappropriate age at vaccine administration (Verbatim: 6-month old male was given the incorrect product formulation for his age). The outcome of the inappropriate age at vaccine administration was not applicable. Additional Information: GSK receipt date: 05-MAY-2025 The physician reported that they discovered an error that occurred in January 2025. The 6-month old patient was given the incorrect product formulation (Menveo) for his age, which led to inappropriate age at vaccine administration. He was given the formulation meant for older children.